WallStSmart
IRD

Opus Genetics, Inc.

NASDAQ: IRD · HEALTHCARE · BIOTECHNOLOGY

$4.99
-6.90% today

Updated 2026-05-08

Market cap
$356.30M
P/E ratio
P/S ratio
25.10x
EPS (TTM)
$-0.80
Dividend yield
52W range
$1 – $6
Volume
0.9M

Opus Genetics, Inc. (IRD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-7.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.1%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$-0.21-78.3%$3.64$3.59-1.4%
2025-11-12$-0.25-89.4%$1.97$1.85-6.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.10$0.00+100.0%
2025-12-31$-0.12$-0.21-78.3%$3.87M-10.2%
2025-09-30$-0.13$-0.25-89.4%$3.08M-20.4%
2025-06-30$-0.19$-0.12+36.8%$2.88M+159.2%
2025-03-31$-0.21$-1.11-442.8%$4.37M+155.4%
2024-12-31$-0.05$-1.27-2573.7%$4.30M+154.4%
2024-09-30$-0.25$-0.29-15.2%$3.87M-67.6%
2024-06-30$-0.24$-0.30-25.0%$1.11M-69.7%
2024-03-31$-0.29$-0.29+0.0%$1.71M
2023-12-31$-0.05$-0.21-320.0%$1.69M
2023-09-30$-0.22$0.25+213.6%$11.94M
2023-06-30$-0.23$-0.24-4.3%$3.67M

Frequently asked questions

Has Opus Genetics, Inc. beaten earnings estimates?
Opus Genetics, Inc. has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -7.7% over the last 4 quarters.
How does IRD stock react to earnings?
IRD stock has moved an average of -3.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.